Keenova Therapeutics plc Finite-Lived Intangible Assets, Net
Keenova Therapeutics plc had Finite-Lived Intangible Assets, Net of $1.72 billion as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2026-08-11
- 2026-06-30: Finite-Lived Intangible Assets, Net $1.72B.
- 2026-03-31: Finite-Lived Intangible Assets, Net $2.17B.
- 2025-12-31: Finite-Lived Intangible Assets, Net $2.23B.
- 2025-09-26: Finite-Lived Intangible Assets, Net $2.54B.
| Period end | Finite-Lived Intangible Assets, Net | Finite-Lived Intangible Assets, Net as first filed |
|---|---|---|
| 2026-06-30 | $1.72B 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $2.17B 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $2.23B 10-Q · filed 2026-08-11 | |
| 2025-09-26 | $2.54B 10-Q · filed 2025-11-10 | |
| 2024-12-27 | $171.70M 10-K · filed 2026-04-15 | $419.40M 10-Q · filed 2025-11-10 |